CN103764664A - 一种硫氰酸红霉素的制备方法 - Google Patents
一种硫氰酸红霉素的制备方法 Download PDFInfo
- Publication number
- CN103764664A CN103764664A CN201280035956.4A CN201280035956A CN103764664A CN 103764664 A CN103764664 A CN 103764664A CN 201280035956 A CN201280035956 A CN 201280035956A CN 103764664 A CN103764664 A CN 103764664A
- Authority
- CN
- China
- Prior art keywords
- erythromycin
- thiocyanate
- solvent
- acetone
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- PGNYNCTUBKSHHL-UHFFFAOYSA-N 2,3-diaminobutanedioic acid Chemical compound OC(=O)C(N)C(N)C(O)=O PGNYNCTUBKSHHL-UHFFFAOYSA-N 0.000 title claims abstract description 59
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 claims abstract description 92
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims abstract description 81
- 229960003276 erythromycin Drugs 0.000 claims abstract description 56
- 239000012535 impurity Substances 0.000 claims abstract description 18
- 239000012046 mixed solvent Substances 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 239000002904 solvent Substances 0.000 claims description 28
- -1 erythromycin salt compounds Chemical class 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 239000002253 acid Substances 0.000 claims description 14
- 230000008859 change Effects 0.000 claims description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 12
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical group CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- 230000033228 biological regulation Effects 0.000 claims description 9
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- 238000002425 crystallisation Methods 0.000 claims description 6
- 230000008025 crystallization Effects 0.000 claims description 6
- 238000005516 engineering process Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- SOIFLUNRINLCBN-UHFFFAOYSA-N ammonium thiocyanate Chemical compound [NH4+].[S-]C#N SOIFLUNRINLCBN-UHFFFAOYSA-N 0.000 claims description 5
- VGTPCRGMBIAPIM-UHFFFAOYSA-M sodium thiocyanate Chemical group [Na+].[S-]C#N VGTPCRGMBIAPIM-UHFFFAOYSA-M 0.000 claims description 5
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 4
- 239000000428 dust Substances 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 239000004210 ether based solvent Substances 0.000 claims description 4
- 150000002576 ketones Chemical class 0.000 claims description 4
- 230000007935 neutral effect Effects 0.000 claims description 4
- 239000003002 pH adjusting agent Substances 0.000 claims description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 238000012986 modification Methods 0.000 claims description 3
- 230000004048 modification Effects 0.000 claims description 3
- ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 claims description 3
- 238000001953 recrystallisation Methods 0.000 claims description 3
- 239000000052 vinegar Substances 0.000 claims description 3
- 235000021419 vinegar Nutrition 0.000 claims description 3
- KKCMGMIPHDNPQL-YZPBMOCRSA-N (3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-6-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione;2-hyd Chemical compound CC(O)C(O)=O.O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 KKCMGMIPHDNPQL-YZPBMOCRSA-N 0.000 claims description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical class ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 2
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical class CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 claims description 2
- 230000001476 alcoholic effect Effects 0.000 claims description 2
- 150000001298 alcohols Chemical class 0.000 claims description 2
- 239000000908 ammonium hydroxide Substances 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 150000002170 ethers Chemical class 0.000 claims description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 claims description 2
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 claims description 2
- 229940011051 isopropyl acetate Drugs 0.000 claims description 2
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 claims description 2
- 230000001590 oxidative effect Effects 0.000 claims description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 2
- 230000029219 regulation of pH Effects 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims 2
- 150000001335 aliphatic alkanes Chemical class 0.000 claims 1
- 150000001913 cyanates Chemical class 0.000 claims 1
- 125000003963 dichloro group Chemical group Cl* 0.000 claims 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 claims 1
- 229910000029 sodium carbonate Inorganic materials 0.000 claims 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 claims 1
- 229960004099 azithromycin Drugs 0.000 abstract description 6
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 abstract description 6
- 229960002626 clarithromycin Drugs 0.000 abstract 1
- AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000047 product Substances 0.000 description 32
- 229930006677 Erythromycin A Natural products 0.000 description 21
- 239000000243 solution Substances 0.000 description 21
- 238000000034 method Methods 0.000 description 18
- 239000000470 constituent Substances 0.000 description 16
- 239000000706 filtrate Substances 0.000 description 12
- 238000004128 high performance liquid chromatography Methods 0.000 description 10
- 238000003756 stirring Methods 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 8
- 239000012043 crude product Substances 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 239000007791 liquid phase Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- XLJMAIOERFSOGZ-UHFFFAOYSA-N cyanic acid Chemical compound OC#N XLJMAIOERFSOGZ-UHFFFAOYSA-N 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000003120 macrolide antibiotic agent Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 230000002924 anti-infective effect Effects 0.000 description 2
- 229960005475 antiinfective agent Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000002288 cocrystallisation Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229940041033 macrolides Drugs 0.000 description 2
- 239000012982 microporous membrane Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000000967 suction filtration Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N thiocyanic acid Chemical compound SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- 241000030538 Thecla Species 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- VXCSPBPIGBJXJR-UHFFFAOYSA-N cyanic acid;sodium Chemical compound [Na].OC#N VXCSPBPIGBJXJR-UHFFFAOYSA-N 0.000 description 1
- QGBSISYHAICWAH-UHFFFAOYSA-N dicyandiamide Chemical compound NC(N)=NC#N QGBSISYHAICWAH-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010812 external standard method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229940124307 fluoroquinolone Drugs 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 239000003348 petrochemical agent Substances 0.000 description 1
- GKKCIDNWFBPDBW-UHFFFAOYSA-M potassium cyanate Chemical class [K]OC#N GKKCIDNWFBPDBW-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000012372 quality testing Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- YFNKIDBQEZZDLK-UHFFFAOYSA-N triglyme Chemical compound COCCOCCOCCOC YFNKIDBQEZZDLK-UHFFFAOYSA-N 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Claims (1)
- PCT国内申请,权利要求书已公开。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201280035956.4A CN103764664B (zh) | 2011-08-26 | 2012-08-24 | 一种硫氰酸红霉素的制备方法 |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110248968.2 | 2011-08-26 | ||
CN201110248968 | 2011-08-26 | ||
CN2011102489682 | 2011-08-26 | ||
CN201280035956.4A CN103764664B (zh) | 2011-08-26 | 2012-08-24 | 一种硫氰酸红霉素的制备方法 |
PCT/CN2012/080554 WO2013029497A1 (zh) | 2011-08-26 | 2012-08-24 | 一种硫氰酸红霉素的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103764664A true CN103764664A (zh) | 2014-04-30 |
CN103764664B CN103764664B (zh) | 2016-03-02 |
Family
ID=47755317
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201280035956.4A Active CN103764664B (zh) | 2011-08-26 | 2012-08-24 | 一种硫氰酸红霉素的制备方法 |
Country Status (8)
Country | Link |
---|---|
US (1) | US9409940B2 (zh) |
EP (1) | EP2749564B1 (zh) |
CN (1) | CN103764664B (zh) |
ES (1) | ES2602171T3 (zh) |
HR (1) | HRP20161370T1 (zh) |
PL (1) | PL2749564T3 (zh) |
SI (1) | SI2749564T1 (zh) |
WO (1) | WO2013029497A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105601687B (zh) * | 2016-03-28 | 2019-05-24 | 四川新迪医药化工有限公司 | 一种硫氰酸红霉素的精制方法 |
CN109912671B (zh) * | 2019-04-12 | 2022-04-26 | 宁夏泰益欣生物科技有限公司 | 一种利用阿维菌素结晶母液提取阿维菌素B2a的方法 |
CN110003295B (zh) * | 2019-04-29 | 2020-05-12 | 宜昌东阳光药业股份有限公司 | 一种硫氰酸红霉素的制备方法 |
CN113201038B (zh) * | 2021-04-13 | 2022-07-26 | 宜昌东阳光生化制药有限公司 | 一种降低硫氰酸红霉素溶剂残留的方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1367842A (fr) * | 1963-07-24 | 1964-07-24 | Pierrel Spa | Procédé de fabrication d'un nouveau sel d'érythromycine soluble dans l'eau |
CN101624412A (zh) * | 2008-07-10 | 2010-01-13 | 刘力 | 大环内酯类衍生物及其制备和用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2791531A (en) * | 1953-10-22 | 1957-05-07 | Lilly Co Eli | Erythromycin thiocyanate and compositions containing same |
GB1013837A (en) | 1962-12-07 | 1965-12-22 | Pierrel Spa | Erythromycin salts and esters |
CN1099039A (zh) * | 1994-05-17 | 1995-02-22 | 陕西省六星科工贸有限公司 | 一种提取红霉素碱的生产工艺 |
CN101407533B (zh) | 2008-11-28 | 2011-06-08 | 宁夏启元药业有限公司 | 一种红霉素硫氰酸盐的生产方法 |
-
2012
- 2012-08-24 CN CN201280035956.4A patent/CN103764664B/zh active Active
- 2012-08-24 WO PCT/CN2012/080554 patent/WO2013029497A1/zh active Application Filing
- 2012-08-24 US US14/240,031 patent/US9409940B2/en active Active
- 2012-08-24 PL PL12827355T patent/PL2749564T3/pl unknown
- 2012-08-24 EP EP12827355.4A patent/EP2749564B1/en active Active
- 2012-08-24 SI SI201230739A patent/SI2749564T1/sl unknown
- 2012-08-24 ES ES12827355.4T patent/ES2602171T3/es active Active
-
2016
- 2016-10-19 HR HRP20161370TT patent/HRP20161370T1/hr unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1367842A (fr) * | 1963-07-24 | 1964-07-24 | Pierrel Spa | Procédé de fabrication d'un nouveau sel d'érythromycine soluble dans l'eau |
CN101624412A (zh) * | 2008-07-10 | 2010-01-13 | 刘力 | 大环内酯类衍生物及其制备和用途 |
Non-Patent Citations (3)
Title |
---|
李平,等: "硫氰酸红霉素合成方法研究", 《中国兽药杂志》 * |
赵茜,等: "红霉素溶析结晶过程中原溶剂对其晶习及纯度的影响研究", 《中国抗生素杂志》 * |
黄阿根,等: "红霉素在丙酮-水***中的溶解度", 《中国抗生素杂志》 * |
Also Published As
Publication number | Publication date |
---|---|
US9409940B2 (en) | 2016-08-09 |
PL2749564T3 (pl) | 2017-07-31 |
EP2749564A1 (en) | 2014-07-02 |
WO2013029497A1 (zh) | 2013-03-07 |
CN103764664B (zh) | 2016-03-02 |
EP2749564A4 (en) | 2015-01-14 |
HRP20161370T1 (hr) | 2016-12-02 |
SI2749564T1 (sl) | 2016-11-30 |
US20140228555A1 (en) | 2014-08-14 |
ES2602171T3 (es) | 2017-02-17 |
EP2749564B1 (en) | 2016-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105884726B (zh) | 丁苯酞的合成方法和纯化工艺 | |
CN105440049B (zh) | 一种制备高纯度米尔贝肟的方法 | |
CN103764664A (zh) | 一种硫氰酸红霉素的制备方法 | |
CN110950780A (zh) | 一种类甲硫酸新斯的明化合物、制备方法及用途 | |
CN102206218B (zh) | 一种高纯度培美曲塞二钠的纯化方法 | |
CN102558182A (zh) | 一种厄他培南钠晶型及其制备方法 | |
CN107501268A (zh) | 一种替比培南酯及其中间体的制备方法 | |
CN104557735A (zh) | 一种高纯度磺胺多辛的制备方法 | |
CN101475539B (zh) | 一种制备高纯度氧嗪酸钾的精制方法 | |
CN104193766B (zh) | 一种头孢他美酸的制备方法 | |
CN104277053B (zh) | 一种头孢地嗪及其中间体头孢地嗪酸的制备方法 | |
CN102391259B (zh) | 一种硝呋太尔化合物及其制法 | |
CN105440054B (zh) | 一种制备头孢硫脒的工艺 | |
CN113549031A (zh) | 一种盐酸苯海索精制方法 | |
CN103724288A (zh) | 原甲酸三乙酯法制备1h-四氮唑乙酸的后处理方法 | |
CN102391326B (zh) | 一种盐酸克林霉素棕榈酸酯化合物及其制法 | |
CN102746244B (zh) | 一种奥替拉西钾的精制方法 | |
CN109081837A (zh) | 美洛西林钠杂质a的分离制备方法 | |
CN105949253B (zh) | 一种盐酸克林霉素的纯化方法 | |
CN106928290A (zh) | 一种高含量芦丁的制备方法 | |
CN105732547A (zh) | 一种脱水穿心莲内酯二酸半酯碱式盐的制备方法 | |
CN104844681B (zh) | 一种l晶型依普利酮的精制方法 | |
CN108912018B (zh) | 一种用于合成舒必利的关键中间体中杂质化合物的制备方法及其用途 | |
CN109490448A (zh) | 一种地高辛标准物质的制备方法 | |
CN106565784B (zh) | 头孢洛林酯二钠盐的纯化方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of erythromycin thiocyanate Effective date of registration: 20191223 Granted publication date: 20160302 Pledgee: Agricultural Bank of China Limited Dongguan Chang'an sub branch Pledgor: HEC Pharm Co., Ltd. Registration number: Y2019440020036 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210310 Granted publication date: 20160302 Pledgee: Agricultural Bank of China Limited Dongguan Chang'an sub branch Pledgor: HEC PHARM Co.,Ltd. Registration number: Y2019440020036 |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210408 Address after: 443300 No.62 Binjiang Road, Lucheng, Yidu, Yichang, Hubei Province Patentee after: Yichang dongyangguang Biochemical Pharmaceutical Co., Ltd Address before: No.62 Binjiang Road, Yidu City, Yichang City, Hubei Province 443300 Patentee before: HEC PHARM Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A preparation method of erythromycin thiocyanate Effective date of registration: 20210928 Granted publication date: 20160302 Pledgee: Agricultural Bank of China Limited Dongguan Chang'an sub branch Pledgor: Yichang dongyangguang Biochemical Pharmaceutical Co., Ltd Registration number: Y2021980010181 |